FDA Prescription Drug User Fee Act Creates Financial Dependence on Pharmaceutical Industry
The Prescription Drug User Fee Act (PDUFA) of 1992 fundamentally restructured FDA drug approval financing by creating a direct financial relationship between pharmaceutical companies and regulators. The Act mandated drug companies pay fees to fund FDA drug reviews, which eventually comprised up to …
Food and Drug Administration
Pharmaceutical Research and Manufacturers of America (PhRMA)
U.S. Congress
Pharmaceutical Companies
regulatory-capture
pharmaceutical-industry
fda
government-funding
institutional-transformation
Read more →